Abbott: ABT Stock to Gain From FDA IDE Approval for Its Coronary IVL System
Abbott's Coronary IVL System wins FDA IDE nod, offering a potential new treatment for arterial calcium blockages.
Read full article »
Chairman & CEO
Robert B. Ford
Abbott is an Illinois-based healthcare company that develops and markets medical devices in fields such as neuroscience and diabetes.
Read more